With continued treatment and gradual dose increases, many patients report minimal side effects by week 4 to 6
JACC Heart Fail 4(7):559566 Jorsal A, Kistorp C, Holmager P, Tougaard RS, Nielsen R, Hnselmann A, Nilsson B, Mller JE, Hjort J, Rasmussen J, Boesgaard TW, Schou M, Videbaek L, Gustafsson I, Flyvbjerg A, Wiggers H, Tarnow L (2017) Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)-a multicentre, double-blind, randomised, placebo-controlled trial
Error 3: Treating all GLP-1 constipation as temporary
Available through most functional medicine labs (GI-MAP, Genova GI Effects, or standalone calprotectin through LabCorp/Quest)
Memeo A., Loiero M